<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">perinatology</journal-id><journal-title-group><journal-title xml:lang="ru">Российский вестник перинатологии и педиатрии</journal-title><trans-title-group xml:lang="en"><trans-title>Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1027-4065</issn><issn pub-type="epub">2500-2228</issn><publisher><publisher-name>Ltd. “The National Academy of Pediatric Science and Innovation”</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21508/1027-4065-2026-71-4-77-84</article-id><article-id custom-type="elpub" pub-id-type="custom">perinatology-2474</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>Качество жизни и детерминанты здоровья у детей с врожденными дефектами иммунитета</article-title><trans-title-group xml:lang="en"><trans-title>Quality of life and health determinants in children with congenital immune defects</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4069-0566</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Барычева</surname><given-names>Л. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Barycheva</surname><given-names>L. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Барычева Людмила Юрьевна — д.м.н., проф., заведующая кафедрой иммунологии с курсом дополнительного профессионального образования.</p><p>355017, Ставрополь, ул. Мира, д. 310</p></bio><bio xml:lang="en"><p>355029, Stavropol</p></bio><email xlink:type="simple">for_ludmila@inbox.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0971-5347</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Козьмова</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kozmova</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Козьмова Наталья Александровна — ассистент кафедры иммунологии с курсом дополнительного профессионального образования/</p><p>355017, Ставрополь, ул. Мира, д. 310</p></bio><bio xml:lang="en"><p>355029, Stavropol</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5823-7479</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Минасян</surname><given-names>М. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Minasyan</surname><given-names>M. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Минасян Милана Михайловна— к.м.н., доцент кафедры иммунологиискурсом дополнительного профессионального образования.</p><p>355017, Ставрополь, ул. Мира, д. 310</p></bio><bio xml:lang="en"><p>355029, Stavropol</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1212-0670</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Быкова</surname><given-names>Г. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Bykova</surname><given-names>G. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Быкова Галина Витальевна — к.м.н., заведующая отделением гематологии и детской онкологии, врач-детский онколог.</p><p>355029, Ставрополь, ул. Семашко, д. 3</p></bio><bio xml:lang="en"><p>355029, Stavropol</p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-5246-0527</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кузнецова</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Kuznetsova</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кузнецова Вера Валентиновна — ассистент кафедры иммунологии с курсом дополнительного профессионального образования.</p><p>355017, Ставрополь, ул. Мира, д. 310</p></bio><bio xml:lang="en"><p>355029, Stavropol</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Голубева</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Golubeva</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Голубева Алина Владимировна — студентка (2 курс, лечебное дело).</p><p>355017, Ставрополь, ул. Мира, д. 310</p></bio><bio xml:lang="en"><p>355029, Stavropol</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Ставропольский государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Regional Children’s Clinical Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ГБУЗ СК «Краевая детская клиническая больница»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Regional Children’s Clinical Hospital</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>05</day><month>10</month><year>2026</year></pub-date><volume>71</volume><issue>4</issue><fpage>77</fpage><lpage>84</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ltd. “The National Academy of Pediatric Science and Innovation”, 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><copyright-holder xml:lang="en">Ltd. “The National Academy of Pediatric Science and Innovation”</copyright-holder><license xlink:href="https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://www.ped-perinatology.ru/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://www.ped-perinatology.ru/jour/article/view/2474">https://www.ped-perinatology.ru/jour/article/view/2474</self-uri><abstract><p>Качество жизни пациентов с врожденными дефектами иммунитета становится предметом пристального внимания в клинической практике. Дети с первичными иммунодефицитами имеют существенные ограничения в повседневной деятельности и нуждаются в помощи многопрофильной команды специалистов.</p><sec><title>Цель исследования</title><p>Цель исследования. Оценка профилей качества жизни у детей с врожденными дефектами иммунитета.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Обследованы 68 детей с врожденными дефектами иммунитета в возрасте от 2 до 18 лет, в том числе с комбинированными (11,8 %), синдромальными (33,9 %) иммунодефицитами, дефектами антител (13,2 %), нарушениями фагоцитоза (14,7 %), наследственным ангиоотеком (11,8 %), расстройствами иммунной регуляции (7,3 %), недифференцированным иммунодефицитом (7,3 %). Анкеты PedsQL 4,0 заполнили 50 детей и 68 родителей. Выполнено исследование физического, эмоционального, социального, школьного и психосоциального доменов качества жизни.</p></sec><sec><title>Результаты</title><p>Результаты. Дети с синдромальными иммунодефицитами несут наибольшее бремя болезни. В этой группе пациентов отмечаются сочетанные дефекты: отставание в физическом развитии, неврологический и когнитивный дефицит, двигательные расстройства и онкологические заболевания (p &lt; 0,001–0,019). Определяется снижение качества жизни во всех сферах — физической активности, общения, школа/сад, психосоциальное функционирование. Пациенты с комбинированными иммунодефицитами имеют удовлетворительные показатели качества жизни, что связано с положительным эффектом трансплантации гемопоэтических стволовых клеток. В группах с высоким общим баллом качества жизни (дефекты антител, наследственный ангиоотек) отмечаются удовлетворительные показатели общения и физической активности. Точкой уязвимости у детей с дефектами антител является функционирование в школе/саду, у пациентов с наследственным ангиоотеком — низкое эмоциональное состояние. В группе с недифференцированными иммунодефицитами наблюдается снижение эмоционального состояния.</p></sec><sec><title>Заключение</title><p>Заключение. Качество жизни детей с первичными иммунодефицитами зависит от вида иммунологического дефекта. Результаты исследования свидетельствуют о необходимости перехода от стандартных к персонализированным программам реабилитации с учетом профилей уязвимости для каждой категории пациентов.</p></sec></abstract><trans-abstract xml:lang="en"><p>The quality of life of patients with congenital defects of immunity has become a subject of close attention in clinical practice. Children with primary immunodeficiencies experience substantial limitations in daily activities and require comprehensive care provided by a multidisciplinary team.</p><sec><title>Objective</title><p>Objective. Assessment of quality of life profiles in children with congenital defects of immunity.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. A total of 68 children aged 2–18 years with congenital defects of immunity were enrolled in the study, including with combined immunodeficiencies (11.8 %), syndromic immunodeficiencies (33.9 %), predominantly antibody deficiencies (13.2 %), phagocytic disorders (14.7 %), hereditary angioedema (11.8 %), immune dysregulation disorders (7.3 %), and unclassified immunodeficiency (7.3 %). PedsQL 4.0 questionnaires were filled out by 50 children and 68 parents. A study of the physical, emotional, social, school, and psychosocial domains of quality of life was performed.</p></sec><sec><title>Results</title><p>Results. Children with syndromic immunodeficiencies bear the greatest burden of the disease. In this group of patients, there are combined defects: delay in physical development, neurological and cognitive deficits, motor disorders and oncological diseases (p &lt; 0.001–0.019). There is a decrease in the quality of life in all areas — physical activity, communication, school/kindergarten performance, psychosocial functioning. Patients with combined immunodeficiencies have satisfactory quality of life indicators, which is associated with the positive effect of hematopoietic stem cell transplantation. In groups with a high overall quality of life score (antibody defects, hereditary angioedema), satisfactory indicators of communication and physical activity are noted. The point of vulnerability in children with antibody defects is functioning in school / kindergarten, in patients with hereditary angioedema — a low emotional state. In the group with undifferentiated immunodeficiencies, a decrease in emotional state is observed.</p></sec><sec><title>Conclusion</title><p>Conclusion. The quality of life of children with primary immunodeficiencies depends on the type of immunological defect. The study results indicate the need to move from standard to personalized rehabilitation programs taking into account the vulnerability profiles of each category of patients.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>врожденные дефекты иммунитета</kwd><kwd>качество жизни</kwd><kwd>состояние здоровья</kwd></kwd-group><kwd-group xml:lang="en"><kwd>congenital defects of immunity</kwd><kwd>quality of life</kwd><kwd>state of health</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Poli C., Aksentijevich I., Bousfiha A.A., Cunningham-Rundles C., Hambleton S., Klein C. et al. Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee. Journal of Human Immunity. 2025;1(1):1. DOI: 10.70962/jhi.20250003.</mixed-citation><mixed-citation xml:lang="en">Poli C., Aksentijevich I., Bousfiha A.A., Cunningham-Rundles C., Hambleton S., Klein C. et al. Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee. Journal of Human Immunity. 2025;1(1):1. DOI: 10.70962/jhi.20250003.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Hsueh J.C., Van Hersh A.T., Zhao W. Immunodeficiency: Burden of Illness. Allergy Asthma Proc. 2024;45(5):294–298. DOI: 10.2500/aap.2024.45.240060.</mixed-citation><mixed-citation xml:lang="en">Hsueh J.C., Van Hersh A.T., Zhao W. Immunodeficiency: Burden of Illness. Allergy Asthma Proc. 2024;45(5):294–298. DOI: 10.2500/aap.2024.45.240060.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Rivière J.G., Carot-Sans G., Piera-Jiménez J., de la Torre S., Cos X., Serra-Picamal X., et al. Development of an Expert-Based Scoring System for Early Identification of Patients with Inborn Errors of Immunity in Primary Care Settings — the PIDCAP Project. J Clin Immunol. 2024;45(1):26. DOI: 10.1007/s10875-024-01825-3.</mixed-citation><mixed-citation xml:lang="en">Rivière J.G., Carot-Sans G., Piera-Jiménez J., de la Torre S., Cos X., Serra-Picamal X., et al. Development of an Expert-Based Scoring System for Early Identification of Patients with Inborn Errors of Immunity in Primary Care Settings — the PIDCAP Project. J Clin Immunol. 2024;45(1):26. DOI: 10.1007/s10875-024-01825-3.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Xiao N., Huang X., Zang W., Kiselev S., Bolkov M.A.,Tuzankina I.A., et al. Health-related quality of life in patients with inborn errors of immunity: a bibliometric analysis. Front Immunol. 2024;15:1371124. DOI: 10.3389/fimmu.2024.1371124.</mixed-citation><mixed-citation xml:lang="en">Xiao N., Huang X., Zang W., Kiselev S., Bolkov M.A.,Tuzankina I.A., et al. Health-related quality of life in patients with inborn errors of immunity: a bibliometric analysis. Front Immunol. 2024;15:1371124. DOI: 10.3389/fimmu.2024.1371124.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Барычева Л.Ю., Хачирова Л.С., Кубанова Л.Т., Душина Л.В., Мухина А.А. Регистр первичных иммунодефицитов в Ставропольском крае. Медицинский вестник Северного Кавказа. 2019;14(4):693-694. DOI: 10.14300/mnnc.2019.14171.</mixed-citation><mixed-citation xml:lang="en">Barycheva L. Yu., Khachirova L. S., Kubanova L. T., Dushchina L.V., Mukhina A.A. Register of primary immunodeficiency in the Stavropol territory. Meditsinskii vestnik Severnogo Kavkaza. 2019;14(4):693-695. (In Russ.). DOI: 10.14300/mnnc.2019.14171.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Berg A.K., Diseth T.H., Abrahamsen T.G., Halvorsen K., Reinfjell T., Erichsen H.C. Primary antibody deficiency: the impact on the quality of life and mental health of affected children and their parents. Acta Paediatr. 2021;110(5):1645–1652. DOI: 10.1111/apa.15752.</mixed-citation><mixed-citation xml:lang="en">Berg A.K., Diseth T.H., Abrahamsen T.G., Halvorsen K., Reinfjell T., Erichsen H.C. Primary antibody deficiency: the impact on the quality of life and mental health of affected children and their parents. Acta Paediatr. 2021;110(5):1645–1652. DOI: 10.1111/apa.15752.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Jiang F., Torgerson T.R., Ayars A.G. Health-related quality of life in patients with primary immunodeficiency disease. Allergy Asthma Clin Immunol. 2015;11:27. DOI: 10.1186/s13223015-0092-y.</mixed-citation><mixed-citation xml:lang="en">Jiang F., Torgerson T.R., Ayars A.G. Health-related quality of life in patients with primary immunodeficiency disease. Allergy Asthma Clin Immunol. 2015;11:27. DOI: 10.1186/s13223015-0092-y.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Peshko D., Kulbachinskaya E., Korsunskiy I., Kondrikova E., Pulvirenti F., Quinti I., et al. Health-related quality of life in children and adults with primary immunodeficiencies: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2019;7(6):1929–1957.e5. DOI: 10.1016/j.jaip.2019.02.013.</mixed-citation><mixed-citation xml:lang="en">Peshko D., Kulbachinskaya E., Korsunskiy I., Kondrikova E., Pulvirenti F., Quinti I., et al. Health-related quality of life in children and adults with primary immunodeficiencies: a systematic review and meta-analysis. J Allergy Clin Immunol Pract. 2019;7(6):1929–1957.e5. DOI: 10.1016/j.jaip.2019.02.013.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Varni J., Seid M., Kurtin P. The PedsQL 4.0: reliability and validity ofthe Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales in healthy and patient populations. Med Care. 2001;39(8):800–812. DOI: 10.1097/00005650200108000-00006.</mixed-citation><mixed-citation xml:lang="en">Varni J., Seid M., Kurtin P. The PedsQL 4.0: reliability and validity ofthe Pediatric Quality of Life Inventory Version 4.0 Generic Core Scales in healthy and patient populations. Med Care. 2001;39(8):800–812. DOI: 10.1097/00005650200108000-00006.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Новик А.А., Ионова Т.И. Исследование качества жизни в педиатрии. 3-е изд., перераб. и доп. / под ред. акад. РАМН Ю. Л. Шевченко. М.: РАЕН; 2017; 181</mixed-citation><mixed-citation xml:lang="en">Novik A.A., Ionova T.I. Study of quality of life in pediatrics. 3rd ed., rev. and enl. / ed. acad. RAMS Yu. L. Shevchenko. M.: RANS; 2017; 181 (In Russ.).</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ng K.F., Goenka A., Manyika F., Bernatoniene J. The Multifaceted Syndromic Primary Immunodeficiencies in Children. Journal of Clinical Medicine. 2023;12(15):4964. DOI: 10.3390/jcm12154964.</mixed-citation><mixed-citation xml:lang="en">Ng K.F., Goenka A., Manyika F., Bernatoniene J. The Multifaceted Syndromic Primary Immunodeficiencies in Children. Journal of Clinical Medicine. 2023;12(15):4964. DOI: 10.3390/jcm12154964.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Karaman S., Hazan F., Erdem S.B., Gülez N., Genel F. Do microdeletions lead to immune deficiency? Cent Eur J Immunol. 2020;45(1):69-72. DOI: 10.5114/ceji.2020.94671.</mixed-citation><mixed-citation xml:lang="en">Karaman S., Hazan F., Erdem S.B., Gülez N., Genel F. Do microdeletions lead to immune deficiency? Cent Eur J Immunol. 2020;45(1):69-72. DOI: 10.5114/ceji.2020.94671.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Szczawinska-Poplonyk A., Begier K., Dorota A., Dabrowska M., Galecka D., Wawrzeniak K., et al. Syndromic immunodeficiencies: a pediatrician’s perspective on selected diseases. Allergol Immunopathol (Madr). 2021;49(4):117-136. DOI: 10.15586/aei.v49i4.200.</mixed-citation><mixed-citation xml:lang="en">Szczawinska-Poplonyk A., Begier K., Dorota A., Dabrowska M., Galecka D., Wawrzeniak K., et al. Syndromic immunodeficiencies: a pediatrician’s perspective on selected diseases. Allergol Immunopathol (Madr). 2021;49(4):117-136. DOI: 10.15586/aei.v49i4.200.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Barkai T., Somech R., Broides A., Gavrieli R., Wolach B., Marcus N., et al. Late diagnosis of chronic granulomatous disease. Clin Exp Immunol. 2020;201:297–305. DOI: 10.1111/cei.13474.</mixed-citation><mixed-citation xml:lang="en">Barkai T., Somech R., Broides A., Gavrieli R., Wolach B., Marcus N., et al. Late diagnosis of chronic granulomatous disease. Clin Exp Immunol. 2020;201:297–305. DOI: 10.1111/cei.13474.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Nicholson B., Goodman R., Day J., Worthet A., Carpenter B., Sandford K., et al. Quality of Life and Social and Psychological Outcomes in Adulthood Following Allogeneic HSCT in Childhood for Inborn Errors of Immunity. J. Clin. Immunol. 2022;42:1451–1460. DOI: 10.1007/s10875-022-01286-6.</mixed-citation><mixed-citation xml:lang="en">Nicholson B., Goodman R., Day J., Worthet A., Carpenter B., Sandford K., et al. Quality of Life and Social and Psychological Outcomes in Adulthood Following Allogeneic HSCT in Childhood for Inborn Errors of Immunity. J. Clin. Immunol. 2022;42:1451–1460. DOI: 10.1007/s10875-022-01286-6.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Bai G., Herten M.H., Landgraf J.M., Korfage I.J., Raat H. Childhood chronic conditions and health-related quality of life: Findings from a large population-based study. PLoS ONE. 2017;12:e0178539. DOI: 10.1371/journal.pone.0178539.</mixed-citation><mixed-citation xml:lang="en">Bai G., Herten M.H., Landgraf J.M., Korfage I.J., Raat H. Childhood chronic conditions and health-related quality of life: Findings from a large population-based study. PLoS ONE. 2017;12:e0178539. DOI: 10.1371/journal.pone.0178539.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">McGlashan H.L., Blanchard C.V., Luscombe C., Prasad M., Chow G., Auer D.P., et al. Quality of life and neurological disability in children and young people with ataxia telangiectasia. Eur J Paediatr Neurol. 2022;40:34–39. DOI: 10.1016/j.ejpn.2022.07.004.</mixed-citation><mixed-citation xml:lang="en">McGlashan H.L., Blanchard C.V., Luscombe C., Prasad M., Chow G., Auer D.P., et al. Quality of life and neurological disability in children and young people with ataxia telangiectasia. Eur J Paediatr Neurol. 2022;40:34–39. DOI: 10.1016/j.ejpn.2022.07.004.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">van Os N.J.H. Quality of life in ataxia-telangiectasia. Eur J Paediatr Neurol. 2022;40:A1. DOI: 10.1016/j.ejpn.2022.08.005.</mixed-citation><mixed-citation xml:lang="en">van Os N.J.H. Quality of life in ataxia-telangiectasia. Eur J Paediatr Neurol. 2022;40:A1. DOI: 10.1016/j.ejpn.2022.08.005.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Shah A.J., Sokolic R., Logan B, Yin Z., Iyengar S., Scalchunes C., et al. Quality of Life of Patients with Wiskott Aldrich Syndrome and X-Linked Thrombocytopenia: a Study of the Primary Immune Deficiency Consortium (PIDTC), Immune Deficiency Foundation, and the Wiskott-Aldrich Foundation. J Clin Immunol. 2019;39(8):786-794. DOI: 10.1007/s10875019-00689-2.</mixed-citation><mixed-citation xml:lang="en">Shah A.J., Sokolic R., Logan B, Yin Z., Iyengar S., Scalchunes C., et al. Quality of Life of Patients with Wiskott Aldrich Syndrome and X-Linked Thrombocytopenia: a Study of the Primary Immune Deficiency Consortium (PIDTC), Immune Deficiency Foundation, and the Wiskott-Aldrich Foundation. J Clin Immunol. 2019;39(8):786-794. DOI: 10.1007/s10875019-00689-2.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Kridli N., Sturza J., Michniacki T.F. Patient-Reported Outcomes and Medical Provider Satisfaction Among Adult and Pediatric Ataxia-Telangiectasia Patients. J Clin Immunol. 2024;44(2):51. DOI: 10.1007/s10875-024-01652-6.</mixed-citation><mixed-citation xml:lang="en">Kridli N., Sturza J., Michniacki T.F. Patient-Reported Outcomes and Medical Provider Satisfaction Among Adult and Pediatric Ataxia-Telangiectasia Patients. J Clin Immunol. 2024;44(2):51. DOI: 10.1007/s10875-024-01652-6.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Joyce P., O’Rourke C., McDermott B., Heussler H. Health-related quality of life in 22q11.2 deletion syndrome: The child’s perspective. J Paediatr Child Health. 2018;54(3):311-315. DOI: 10.1111/jpc.13746.</mixed-citation><mixed-citation xml:lang="en">Joyce P., O’Rourke C., McDermott B., Heussler H. Health-related quality of life in 22q11.2 deletion syndrome: The child’s perspective. J Paediatr Child Health. 2018;54(3):311-315. DOI: 10.1111/jpc.13746.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Abd Hamid I.J., Slatter M.A., McKendrick F., Pearce M.S., Gennery A.R. Long-term health outcome and quality of life post-HSCT for IL7Ra-, Artemis-, RAG1and RAG2-deficient severe combined immunodeficiency: a single centre report. J Clin Immunol. 2018;38(6):727–732. DOI: 10.1007/s10875-018-0540-9.</mixed-citation><mixed-citation xml:lang="en">Abd Hamid I.J., Slatter M.A., McKendrick F., Pearce M.S., Gennery A.R. Long-term health outcome and quality of life post-HSCT for IL7Ra-, Artemis-, RAG1and RAG2-deficient severe combined immunodeficiency: a single centre report. J Clin Immunol. 2018;38(6):727–732. DOI: 10.1007/s10875-018-0540-9.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Piotrowicz-Wójcik K., Bulanda, M., Czarnobilska, E., Porebski, G. Clinical Characteristics and Quality of Life in a Cohort of Polish Pediatric Patients with Hereditary Angioedema. Children. 2024;11(2):237. DOI: 10.3390/children11020237.</mixed-citation><mixed-citation xml:lang="en">Piotrowicz-Wójcik K., Bulanda, M., Czarnobilska, E., Porebski, G. Clinical Characteristics and Quality of Life in a Cohort of Polish Pediatric Patients with Hereditary Angioedema. Children. 2024;11(2):237. DOI: 10.3390/children11020237.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
